Metabolism of theophylline by cDNA‐expressed human cytochromes P‐450.
Open Access
- 1 March 1995
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 39 (3) , 321-326
- https://doi.org/10.1111/j.1365-2125.1995.tb04455.x
Abstract
1. Theophylline metabolism was studied using seven human cytochrome P‐ 450 isoforms (CYPs), namely CYP1A1, 1A2, 2A6, 2B6, 2D6, 2E1 and 3A4, and microsomal epoxide hydroxylase (EH), expressed in human B‐ lymphoblastoid cell lines. 2. At a high theophylline concentration of 10 mM four CYPs (1A1, 1A2, 2D6, 2E1) catalyzed the metabolism of theophylline. 3. Theophylline had the highest affinity (apparent Km range 0.2‐1.0 mM) for the CYP1A subfamily and the kinetics of metabolic formation mediated by CYP1A2 indicated substrate‐inhibition (Ki range 9‐ 16 mM). 4. CYP1A2 catalyzed the demethylation of theophylline as well as its hydroxylation, and was associated with the highest intrinsic clearance (1995 l h‐1 per mol CYP) to 1,3‐dimethyluric acid (DMU). Therefore, this isoform can be considered to be the most important enzyme involved in theophylline metabolism in vitro. 5. CYP2E1 was responsible for a relatively high intrinsic clearance by 8‐ hydroxylation (289 l h‐1 per mol CYP). The apparent Km value of this reaction was about 15 mM, suggesting that CYP2E1 may be the low‐ affinity high‐capacity isoform involved in theophylline metabolism. 6. The affinity of theophylline for CYP1A1 was comparable with that of its homologue 1A2. When induced, the participation of CYP1A1 in theophylline metabolism may be important. 7. CYP2D6 played only a minor role and CYP3A4 was not active in the in vitro metabolism of theophylline. 8. Our findings confirm the major role of CYP1A2 in theophylline metabolism and explain why in vivo the elimination kinetics of theophylline are non‐linear and in vitro theophylline metabolism by human liver microsomes does not obey monophasic kinetics. 9. The data suggest also that not only tobacco smoking but also chronic alcohol intake may influence theophylline elimination in man as ethanol induces CYP2E1.Keywords
This publication has 35 references indexed in Scilit:
- Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1Pharmacogenetics, 1992
- Localization of CYP1A1 and CYP1A2 messenger RNA in normal human liver and in hepatocellular carcinoma by in situ hybridizationHepatology, 1991
- Pharmacokinetic Interactions Between Theophylline and Other Medication (Part I)1Clinical Pharmacokinetics, 1991
- Characterisation of theophylline metabolism by human liver microsomesBiochemical Pharmacology, 1988
- Characterization of the common genetic defect in humans deficient in debrisoquine metabolismNature, 1988
- Characterization of ethanol-inducible human liver N-nitrosodimethylamine demethylaseBiochemistry, 1986
- Polymorphism of theophylline metabolism in man.Journal of Clinical Investigation, 1985
- Factors affecting theophylline clearances: Age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanolJournal of Pharmaceutical Sciences, 1979
- Clinical Pharmacokinetics of TheophyllineClinical Pharmacokinetics, 1978
- Theophylline Disposition in Patients with Hepatic CirrhosisNew England Journal of Medicine, 1977